Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmaceutical Sciences Asia is Scopus-indexed (Q3, CiteScore 1.1), DOAJ. Published by Mahidol University - Faculty of Pharmacy.
Checked against the index lists dated .
ISSN 2586-8195Verify ISSN ↗2586-8470Verify ISSN ↗
Publisher: Mahidol University - Faculty of Pharmacy
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 59 / 79 | 25th | Q3 |
| Pharmacology (medical) | 216 / 278 | 22nd | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q3, CiteScore 1.1.
Pharmaceutical Sciences Asia is Q3 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 59 of 79) and Q4 in Pharmacology (medical) (rank 216 of 278), by CiteScore 2025.
Pharmaceutical Sciences Asia is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.1, quartile Q3, 25th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.189, quartile Q3, with an H-index of 11.
Pharmaceutical Sciences Asia is published by Mahidol University - Faculty of Pharmacy. Its print ISSN is 2586-8195 and its online ISSN is 2586-8470.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Pharmaceutical Sciences Asia has an h-index of 12 and a 2-year mean of 0.56 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q3. On 2-year citations it ranks #55 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Pharmaceutical Sciences Asia published 36 papers in 2025; its busiest recent year was 2022 with 66. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2024–2026), authors are most often from Thailand (48.4%), Vietnam (14.9%) and India (11.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.